E645-0859 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]acetamide

E645-0859 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]acetamide
E645-0859 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E645-0859
2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E645-0859

Molecular Formula

C24H20ClN3O5 (C24 H20 ClN3 O5)

Compound Name

2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]acetamide

IUPAC name

2-{13-chloro-9-oxo-2-oxa-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-10-yl}-N-[1-(23-dihydro-14-benzodioxin-6-yl)ethyl]acetamide

SMILES

CC(c(cc1)cc2c1OCCO2)NC(CN(c(cc(cc1)Cl)c1Oc1c2cccn1)C2=O)=O

InChI

InChI=1S/C24H20ClN3O5/c1-14(15-4-6-20-21(11-15)32-10-9-31-20)27-22(29)13-28-18-12-16(25)5-7-19(18)33-23-17(24(28)30)3-2-8-26-23/h2-8,11-12,14H,9-10,13H2,1H3,(H,27,29)/t14-/m0/s1

InChI Key

IPNJXGDWPLVNAS-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD14907646

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.89

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.872

Distribution Coefficient, logD

2.872

Water Solubility, LogSw

-3.85

Polar Surface Area

71.990

Acid Dissociation Constant (pKa)

14.71

Base Dissociation Constant (pKb)

0.08

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.80

E645-0859 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E645-0859 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E645-0859?
Check Price and Availability of E645-0859, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E645-0859 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E645-0859
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E645-0859
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E645-0859 available by request